CMF
HAE icon

Counterpoint Mutual Funds’s Haemonetics HAE Stock Holding History

Counterpoint Mutual Funds’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,295
Closed -$505K – 379
2025
Q4 		$505K Buy
+6,295
New +$423K 0.04% 121
2023
Q3 		– Sell
-1,191
Closed -$101K – 379
2023
Q2 		$101K Buy
+1,191
New +$101K 0.09% 236

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Counterpoint Mutual Funds's HAE Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 6,295 shares — an estimated $505K sold.

Counterpoint Mutual Funds first reported a position in HAE in Q2 2023 and held it in 2 quarters. The position peaked at $505K in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Counterpoint Mutual Funds reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 6,295 Haemonetics shares in Q1 2026, an estimated $505K.
  • Counterpoint Mutual Funds first reported a position in Haemonetics in Q2 2023 and held it in 2 quarters.
  • Counterpoint Mutual Funds's Haemonetics position peaked at $505K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.